Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...

Paediatricians across India raise alarm over increasing child medication overdoses caused by confusing drug formulations.

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Pharmacokinetic and safety studies were analyzed to demonstrate the safety and efficacy of TRN-257, as well as previous research on oxybate products.

Southwest Research Institute (SwRI) and Trinity University are developing an intranasal (IN) drug-device combination to treat ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Formosa and Rxilient have an exclusive licensing agreement for APP13007 commercialization, including regulatory and sales ...